GlassScriptPhysician profile
Julia E Bousquet
NPI 1831771609
$931.64
in general payments reported to CMS, 2019-2025
15 companies · $69.47 in 2025
The $69.47 reported for 2025 was less than what a typical Psychiatric/Mental Health, Child & Family provider received nationally (typical 2025 total: $178).
See the full distribution for Psychiatric/Mental Health, Child & Family
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $114 · 2022: $437 · 2023: $238 · 2024: $72.95 · 2025: $69.47.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $380.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $380.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neurocrine Biosciences, INC. | $246.62 | 2022-2023 | Ingrezza |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $165.48 | 2021-2023 | |
| Corium, LLC | $139.40 | 2022-2025 | Azstarys |
| Lundbeck LLC | $71.82 | 2022-2023 | Rexulti |
| Vanda Pharmaceuticals INC. | $48.46 | 2022-2025 | Fanapt |
| Otsuka America Pharmaceutical, INC. | $36.99 | 2022-2024 | Rexulti |
| Abbvie INC. | $35.73 | 2023 | |
| Takeda Pharmaceuticals U.S.A., INC. | $34.74 | 2023 | Trintellix |
| E.R. Squibb & Sons, L.L.C. | $34.07 | 2024 | Cobenfy |
| Neos Therapeutics, LP | $23.15 | 2022 | |
| Ironshore Pharmaceuticals INC. | $22.20 | 2021 | |
| Axsome Therapeutics, INC. | $18.99 | 2023 | Auvelity |
| Alkermes, INC. | $18.59 | 2023 | Vivitrol |
| Vertical Pharmaceuticals, LLC | $18.59 | 2024 | Relexxii |
| Collegium Pharmaceutical, INC. | $16.81 | 2025 | Jornay Pm |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Julia Bousquet listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.